RecruitingNCT05181826

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Sponsor

Helio Genomics

Enrollment

1,200 participants

Start Date

May 21, 2019

Study Type

OBSERVATIONAL

Conditions

Cancer COPD Diabetes Liver Cirrhosis Hepatitis B Hepatitis C Chronic Hepatitis

Summary

To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Multi-analyte Blood Test for people with copd, cancer, and other related conditions. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.